Jane L. Holley

643 total citations
21 papers, 520 citations indexed

About

Jane L. Holley is a scholar working on Neurology, Immunology and Molecular Biology. According to data from OpenAlex, Jane L. Holley has authored 21 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Jane L. Holley's work include Botulinum Toxin and Related Neurological Disorders (9 papers), Toxin Mechanisms and Immunotoxins (7 papers) and Transgenic Plants and Applications (5 papers). Jane L. Holley is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (9 papers), Toxin Mechanisms and Immunotoxins (7 papers) and Transgenic Plants and Applications (5 papers). Jane L. Holley collaborates with scholars based in United Kingdom, United States and Sweden. Jane L. Holley's co-authors include Richard W. Titball, Gareth Griffiths, Gary Phillips, Gerald M. Cohen, Paul M. Cullis, Michael Byrne, Leonard A. Smith, John J. Reynolds, Rosalind M. Hembry and Murray C. Meikle and has published in prestigious journals such as Infection and Immunity, Archives of Biochemistry and Biophysics and International Journal of Pharmaceutics.

In The Last Decade

Jane L. Holley

21 papers receiving 493 citations

Peers

Jane L. Holley
Matthieu Delincé Switzerland
Juliette Molnos Switzerland
Michael Chang United States
Junqing Shen United States
Steven M. Vroegop United States
Anne Clancy Germany
Jane L. Holley
Citations per year, relative to Jane L. Holley Jane L. Holley (= 1×) peers K Matsuyama

Countries citing papers authored by Jane L. Holley

Since Specialization
Citations

This map shows the geographic impact of Jane L. Holley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane L. Holley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane L. Holley more than expected).

Fields of papers citing papers by Jane L. Holley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane L. Holley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane L. Holley. The network helps show where Jane L. Holley may publish in the future.

Co-authorship network of co-authors of Jane L. Holley

This figure shows the co-authorship network connecting the top 25 collaborators of Jane L. Holley. A scholar is included among the top collaborators of Jane L. Holley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane L. Holley. Jane L. Holley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stoll, Alexander, et al.. (2023). Comparative Aspects of Ricin Toxicity by Inhalation. Toxins. 15(4). 281–281. 3 indexed citations
2.
Knight, Simon A.B., et al.. (2020). Establishment of a Novel Oral Murine Model of Ricin Intoxication and Efficacy Assessment of Ovine Ricin Antitoxins. Toxins. 12(12). 784–784. 2 indexed citations
3.
Griffiths, Gareth, et al.. (2017). Production, Characterisation and Testing of an Ovine Antitoxin against Ricin; Efficacy, Potency and Mechanisms of Action. Toxins. 9(10). 329–329. 8 indexed citations
4.
Griffiths, Gareth, Gary Phillips, & Jane L. Holley. (2007). Inhalation Toxicology of Ricin Preparations: Animal Models, Prophylactic and Therapeutic Approaches to Protection. Inhalation Toxicology. 19(10). 873–887. 51 indexed citations
6.
Bennett, Alice M., Stuart D. Perkins, & Jane L. Holley. (2003). DNA vaccination protects against botulinum neurotoxin type F. Vaccine. 21(23). 3110–3117. 32 indexed citations
7.
Holley, Jane L., et al.. (2003). Anti‐immunoglobulin Responses to IgG, F(ab′)2, and Fab Botulinum Antitoxins in Mice. Immunopharmacology and Immunotoxicology. 25(3). 397–408. 11 indexed citations
8.
Foynes, Susan, Jane L. Holley, Helen S. Garmory, Richard W. Titball, & Neil F. Fairweather. (2003). Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F HC fragment. Vaccine. 21(11-12). 1052–1059. 17 indexed citations
9.
Holley, Jane L., et al.. (2001). Antitoxin therapy for botulinum intoxication. Reviews in Medical Microbiology. 12(1). 29–37. 20 indexed citations
10.
Holley, Jane L., et al.. (2000). Cloning, expression and evaluation of a recombinant sub-unit vaccine against Clostridium botulinum type F toxin. Vaccine. 19(2-3). 288–297. 33 indexed citations
11.
Walker, Nicola J., Jane L. Holley, C.E. Naylor, et al.. (2000). Identification of Residues in the Carboxy-Terminal Domain of Clostridium perfringens α-Toxin (Phospholipase C) Which Are Required for Its Biological Activities. Archives of Biochemistry and Biophysics. 384(1). 24–30. 14 indexed citations
12.
Byrne, Michael, Richard W. Titball, Jane L. Holley, & Leonard A. Smith. (2000). Fermentation, Purification, and Efficacy of a Recombinant Vaccine Candidate against Botulinum Neurotoxin Type F from Pichia pastoris. Protein Expression and Purification. 18(3). 327–337. 57 indexed citations
13.
Howells, Angela M., Helen L. Bullifent, Barbara Bolgiano, et al.. (1999). Differences in the Carboxy-Terminal (Putative Phospholipid Binding) Domains of Clostridium perfringens and Clostridium bifermentans Phospholipases C Influence the Hemolytic and Lethal Properties of These Enzymes. Infection and Immunity. 67(7). 3297–3301. 27 indexed citations
14.
Verschoyle, Richard D., P. Carthew, Jane L. Holley, Paul M. Cullis, & Gerald M. Cohen. (1994). The comparative toxicity of chlorambucil and chlorambucil-spermidine conjugate to BALBc mice. Cancer Letters. 85(2). 217–222. 15 indexed citations
15.
Meikle, Murray C., et al.. (1994). Immunolocalization of matrix metalloproteinases and TIMP‐1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patients. Journal of Periodontal Research. 29(2). 118–126. 69 indexed citations
16.
Holley, Jane L., et al.. (1992). Uptake and cytotoxicity of novel nitroimidazole-polyamine conjugates in ehrlich ascites tumour cells. Biochemical Pharmacology. 43(4). 763–769. 28 indexed citations
17.
Tóth, István, et al.. (1992). Lipidic peptides. VIII. Cellular uptake studies of lipidic amino acid, its oligomers and highly lipophilic drug conjugates. International Journal of Pharmaceutics. 79(1-3). 39–45. 8 indexed citations
18.
Wood, Ian P., István Tóth, Jane L. Holley, & William A. Gibbons. (1992). Lipidic peptides. XIII: Synthesis, structure elucidation and in vitro toxicity assessment of chlorambucil conjugates with lipidic acids, lipidic amino acids and their oligomers. International Journal of Pharmaceutics. 87(1-3). 141–147. 5 indexed citations
19.
Tóth, István, Esther del Olmo, Jane L. Holley, et al.. (1992). Lipidic peptides. XII. Cellular uptake studies of a lipidic amino acid, its oligomers and highly lipophilic drug conjugates on Ehrlich ascites tumour cells. International Journal of Pharmaceutics. 83(1-3). 131–138. 2 indexed citations
20.
Holley, Jane L., Richard T. Wheelhouse, Paul M. Cullis, et al.. (1992). Targeting of tumor cells and DNA by a chlorambucil-spermidine conjugate.. PubMed. 52(15). 4190–5. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026